Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure

Redox Report

Volumn 19, Issue 3, 2014, Pages 118-123

  Ellidag, Hamit Yasar ^a   Eren, Esin ^b   Yilmaz, Necat ^a   Cekin, Yesim ^a  

^a Research Hospital of Ministry of Health   (Turkey)

^b Antalya Public Health Center of Ministry of Health   (Turkey)

Author keywords

Albumin; Heart failure; Ischemia modified albumin; Oxidative stress

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN ADJUSTED ISCHEMIA MODIFIED ALBUMIN; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ISCHEMIA MODIFIED ALBUMIN; OXIDIZING AGENT; SERUM ALBUMIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; ISCHEMIA-MODIFIED ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CELLULAR PARAMETERS; CHRONIC ISCHEMIC HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXIDATIVE STRESS INDEX; PRIORITY JOURNAL; TOTAL OXIDANT STATUS; VERY ELDERLY; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; METABOLISM;

AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; SERUM ALBUMIN;

EID: 84897491287     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000213Y.0000000083     Document Type: Article

References (39)

1. Babick AP, Dhalla NS. Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure. Med Princ Pract 2007;16(2):81-9.
2. Rogowski O, Shnizer S, Wolff R, Lewis BS, Amir O. Increased serum levels of oxidative stress are associated with hospital readmissions due to acute heart failure. Cardiology 2011;118:33-7.
3. Kumar EP, Mukherjee R, Senthil R, Parasuraman S, Suresh B. Evaluation of oxidative stress and antioxidant status in patients with cardiovascular disease in rural populations of the nilgiris, South India. ISRN Pharmacol 2012; doi: 10.5402/2012/941068.
4. Chen J, Mehta JL. Role of oxidative stress in coronary heart disease. Indian Heart J 2004;56:163-73.
5. Taverna M, Marie AL, Mira JP, Guidet B. Specific antioxidant properties of human serum albumin. Ann Intensive Care 2013; 3(4):2-7.
6. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, et al. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464-70.
7. Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, et al. Ischemiamodified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004;97: 297-301.
8. Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, et al. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise induced skeletal muscle ischemia. Clin Chem 2004;50:1656-60.
9. Gidenne S, Ceppa F, Fontan E, Perrier F, Burnat P. Analytical performance of the albumin cobalt binding (ACB) test on the CobasMIRA Plus analyzer. Clin Chem Lab Med 2004;42: 455-61.
10. American Heart Association AHA Medical/Scientific Statement. 1994 revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. Circulation 1994;90:644-5.
11. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. Emerg Med J 2000;19(4):311-5.
12. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Standardization of ischaemia modified albumin testing: adjustment for serum albumin. Clin Chem Lab Med 2007;45:261-2.
13. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-11.
14. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generationmore stable ABTS radical cation. Clin Biochem 2004;37:277-85.
15. Harma M, Harma M, Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003;133: 563-66.
16. Montagnana M, Lippi G, Volpe A, Salvagno GL, Biasi D, Caramaschi P, et al. Evaluation of cardiac laboratory markers in patients with systemic sclerosis. Clin Biochem 2006;39:913-17.
17. Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, et al. Ischemia modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 2004;50:1656-60.
18. Piwowar A, Knapik-Kordecka M, Warwas M. Ischemia-modified albumin level in type 2 diabetes mellitus-preliminary report. Dis Markers 2008;24:311-17.
19. Chang D, Sha Q, Zhang X, Liu P, Rong S, Han T, et al. The evaluation of the oxidative stress parameters in patients with primary angle-closure glaucoma. PLoS ONE 2011;6(11):e27218.
20. Franceschi F, Deharo JC, Giorgi R, By Y, Monserrat C, Condo J, et al. Peripheral plasma adenosine release in patients with chronic heart failure. Heart 2009;95:651-5.
21. Van der Zee PM, Verberne HJ, van Straalen JP, Sanders GT, Van Eck-Smit BL, de Winter RJ, et al. Ischemia-modified albumin measurements in symptom limited exercise myocardial perfusion scintigraphy reflect serum albumin concentrations but not myocardial ischemia. Clin Chem 2005;51:1744-46.
22. Ellidag HY, Eren E, Yilmaz N, Bayindir A. Ischemia modified albumin levels and increased oxidative stress in patients with multiple myeloma. J Med Biochem 2013:32;1-7.
23. Ellidag HY, Eren E, Aydi{dotless}n O, Akgol E, Yalci{dotless}nkaya S, Sezer C, et al. Ischemia modified albumin levels and increased oxidative stress in patients with bladder cancer. Asian Pac J Cancer Prev 2013;14(5):2157-61.
24. Arthur PG, Grounds MD, Shavlakadze T. Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions. Curr Opin Clin Nutr Metab Care 2008; 11:408-16.
25. Russell ST, Eley H, Tisdale MJ. Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysis-inducing factor and angiotensin II. Cell Signal 2007;19: 1797-806.
26. Vaughan VC, Martin P, Lewandowski PA. Cancer cachexia: impact, mechanisms and emerging treatments. J Cachexia Sarcopenia Muscle 2013;4(2):95-109.
27. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J 2008;155:883-89.
28. Uthamalingam S, Kandala J, Daley M, Patvardhan E, Capodilupo R, Moore SA, et al. Serum albumin and mortality in acutely decompensated heart failure. Am Heart J 2010;160: 1149-55.
29. Kato M, Sugihara S, Hirai M. Geriatric nutritional risk index predicts functional dependency and mortality in patients with heart failure with preserved ejection fraction. Circ J. 2013;77(3):705-11.
30. von Haehling S, Lainscak M, Springer J, Anker SD. Cardiac cachexia: a systematic overview. Pharmacol Ther 2009;121: 227-52.
31. Chojkier M. Inhibition of albumin synthesis in chronic diseases: molecular mechanisms. J Clin Gastroenterol 2005;39(4 Suppl. 2):S143-6.
32. Adlbrecht C, Kommata S, Hulsmann M, Szekeres T, Bieglmayer C, Strunk G, et al. Chronic heart failure leads to an expended plasma volume and pseudoanemia, but does not lead to a reduction in the body's red cell volume. Eur Heart J 2008;29: 2343-50.
33. Kataoka H. Short term changes in hematologic and biochemical tests during follow-up of definite heart failure patients. Int J Cardiol 2010;144:441-4.
34. Ajayi AA, Adigun AQ, Ojofeitimi EO, Yusuph H, Ajayi OE. Anthropometric evaluation of cachexia in chronic congestive heart failure: the role of tricuspid regurgitation. Int J Cardiol 1999;71:79-84.
35. Michelis R, Kristal B, Snitkovsky T, Sela S. Oxidative modifications impair albumin quantification. BBRC 2010;401:137-42.
36. Naffaa M, Makhoul BF, Tobia A, Jarous M, Kaplan M, Aronson D, et al. Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure. Am J Emerg Med 2014;32(1):44-9.
37. Kinugasa Y, Kato M, Sugihara S, Hirai M, Yamada K, Yanagihara K, et al. Geriatric nutritional risk index predicts functional dependency and mortality in patients with heart failure with preserved ejection fraction. Circ J 2013;77(3):705-11.
38. Yilmaz N, Aydin O, Yegin A, Tiltak A, Eren E. Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs. Clin Biochem 2011;44:832-7.
39. Yilmaz N, Aydin O, Yegin A, Tiltak A, Eren E, Aykal G. Impaired oxidative balance and association of blood glucose, insulin and HOMA-IR index in migraine. Biochem Med 2011; 21:145-51.